AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Ronapreve 120mg Injection Combi Pack

Prescription Icon
Prescription Required

Marketer

Cipla Ltd

Salt Composition

Casirivimab (120mg/ml) + Imdevimab (120mg/ml)

Overview Ronapreve 120mg Injection Combi Pack

The Ronapreve 120mg combination injection treats mild to moderate COVID-19 in adults and children (12+ years, >40kg). This dual monoclonal antibody therapy is most effective when administered within 7-10 days of a positive lab test. Approved by India's CDSCO (May 3, 2021), and also authorized in the US, Switzerland, Germany, France, Italy, and other nations, Ronapreve is intravenously or subcutaneously injected by medical professionals, ideally in a hospital setting. Potential side effects, including serious allergic reactions, necessitate post-injection monitoring (minimum 1 hour). Common side effects include injection site reactions, fever, flushing, respiratory distress, nausea, and vomiting; report any adverse effects immediately. Inform your physician of pre-existing conditions and other medications before treatment, as interactions are possible. Use in pregnancy or breastfeeding is evaluated on a case-by-case basis. For information on availability or administration locations, please provide your details here; we will contact you shortly.

Uses of Ronapreve 120mg Injection Combi Pack

Managing mild-to-moderate cases of COVID-19

Major Benefits of Ronapreve 120mg Injection Combi Pack:

Follow your doctor's instructions precisely regarding dosage and treatment length. Always review the medication label prior to administration.

Common Side effects of Ronapreve 120mg Injection Combi Pack:

  • Injection site reactions (pain, swelling, redness)
  • Fever
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Breathlessness
  • Chest tightness
  • Nausea
  • Vomiting

How to use Ronapreve 120mg Injection Combi Pack:

Follow your doctor's instructions precisely regarding dosage and treatment length. Always verify the product information before administration.

How Ronapreve 120mg Injection Combi Pack works:

Ronapreve's dual-antibody injection (120mg) combines two distinct human IgG1 monoclonal antibodies. These antibodies target separate sites on the SARS-CoV-2 spike protein, preventing viral entry into human cells. Engineered through recombinant DNA technology, this approach demonstrates consistent efficacy against current and newly emerging COVID-19 variants by blocking viral receptor attachment.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Ronapreve 120mg Injection Combi Pack is of uncertain safety. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on the use of the Ronapreve 120mg combination injection during pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Ronapreve 120mg Injection Combi Pack with breastfeeding is currently lacking. Seek medical advice from your physician.

DrivingDrivingSAFE

The combined Ronapreve 120mg injection typically has no impact on driving ability.

KidneyKidneySAFE IF PRESCRIBED

The combined Ronapreve 120mg injection is likely safe for individuals with impaired kidney function. Current evidence indicates dose modification may not be necessary, but physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of the Ronapreve 120mg Injection Combi Pack to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Ronapreve 120mg Injection Combi Pack :

Should you forget a dose of the Ronapreve 120mg combination injection, seek medical advice.

Facts to Know About Ronapreve 120mg Injection Combi Pack

LabelValue
Developing Habits No.

FAQs on Ronapreve 120mg Injection Combi Pack

Ronapreve 120mg Injection Combi Pack contains the monoclonal antibodies casivimab and imdevimab. These antibodies act like the body's natural defenses, targeting and neutralizing the SARS-CoV-2 virus, which causes COVID-19.
A monoclonal antibody cocktail combines individually available monoclonal antibodies for simultaneous administration.
The COVID-19 virus, SARS-CoV-2, uses a surface spike protein to invade human cells. Monoclonal antibody treatments counteract this, mimicking the spike protein's attachment to prevent infection. Early intervention with monoclonal antibodies may alleviate mild initial symptoms.
COVID-19 monoclonal antibody therapy is indicated for patients 12 years and older weighing at least 40 kg, following early diagnosis. It's also appropriate for high-risk individuals, including those 60 and older, with comorbidities like diabetes or hypertension, or those with compromised immune systems.
COVID-19 monoclonal antibody treatment is unsuitable for hospitalized patients or those requiring oxygen therapy, including those needing oxygen due to pre-existing conditions unrelated to COVID-19. Individuals with allergies to Ronapreve 120mg Injection Combi Pack components should also avoid this treatment.
Older adults (60+), obese individuals, and those with pre-existing lung, kidney (including dialysis patients), or liver conditions, or weakened immune systems (e.g., cancer patients), face a significantly elevated risk of severe COVID-19.
Ronapreve 120mg Injection Combi Pack is administered intravenously or subcutaneously by a healthcare professional in a hospital setting to treat mild to moderate COVID-19 symptoms. Intramuscular injection is contraindicated.
Ronapreve 120mg Injection Combi Pack may be used by patients with high blood pressure or diabetes under a doctor's supervision. Available data suggests the benefits of this monoclonal antibody therapy outweigh potential risks.
Ronapreve 120mg Injection...
1,03,250
MRP 1,19,500
13% off